ORGANOGENESIS INC
10-Q, EX-27, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ORGANOGENESIS INC, 10-Q, EX-10.(EE), 2000-11-14
Next: SUN LIFE INSURANCE & ANNUITY CO OF NEW YORK, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENT.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          14,976
<SECURITIES>                                     3,355
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                        892
<CURRENT-ASSETS>                                20,633
<PP&E>                                          24,893
<DEPRECIATION>                                  12,707
<TOTAL-ASSETS>                                  33,294
<CURRENT-LIABILITIES>                            5,693
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           345
<OTHER-SE>                                       8,127
<TOTAL-LIABILITY-AND-EQUITY>                    33,294
<SALES>                                          2,050
<TOTAL-REVENUES>                                 8,898
<CGS>                                            3,744
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                19,288
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,547
<INCOME-PRETAX>                               (15,681)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (15,681)
<EPS-BASIC>                                      (.47)
<EPS-DILUTED>                                    (.47)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission